Sector
Healthcare sector explained
Companies that make medicines, vaccines and medical devices, and those that run hospitals and diagnostic labs.
Companies we cover
14 companies in Healthcare
Apollo Hospitals
APOLLOHOSPApollo Hospitals treats patients in 48 hospitals of its own and supplies 7,662 Apollo pharmacies; FY26 revenue was ₹24,774 crore.
Filings cover: A lotUpdated for Q2 FY27 · checked
Aurobindo Pharma
AUROPHARMAAurobindo Pharma makes generic medicines and drug ingredients, mostly sold in the US and Europe, and earned ₹33,653 crore of revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Cipla
CIPLACipla makes medicines, including inhalers for breathing conditions, and sells them in India, the US, Africa and other markets, earning ₹28,163 crore of revenue in FY26.
Filings cover: A lotUpdated for Q2 FY27 · checked
Divi's Laboratories
DIVISLABDivi's Laboratories makes medicine ingredients for drug companies, mostly abroad, earning ₹10,560 crore of revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Dr. Reddy's
DRREDDYDr. Reddy's makes generic and branded medicines and their ingredients, and sells them in 87 countries; FY26 revenue was ₹33,700 crore.
Filings cover: A lotUpdated for Q2 FY27 · checked
Lupin
LUPINLupin makes generic medicines for the US and branded medicines for India, earning ₹27,958 crore of revenue in FY26.
Filings cover: A lotUpdated for Q2 FY27 · checked
Marksans Pharma
MARKSANSMarksans Pharma makes generic medicines, mostly over-the-counter products such as painkillers, for the US, UK, Europe and Australia, earning ₹2,951 crore of revenue in FY26.
Filings cover: A lotUpdated for Q2 FY27 · checked
Max Healthcare
MAXHEALTHMax Healthcare runs private hospitals, mainly in metro cities and especially Delhi NCR, and earned ₹8,373 crore of consolidated revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Morepen Laboratories
MOREPENLABMorepen Laboratories makes medicine ingredients for drug companies and glucose meters for home use, earning ₹1,806 crore of revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Natco Pharma
NATCOPHARMNatco Pharma develops complex generic medicines that partner companies sell in the US, and sells cancer medicines in India, earning ₹4,078 crore of revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Piramal Pharma
PPLPHARMAPiramal Pharma makes medicines under contract for other drug companies, sells anaesthesia and other hospital medicines, and owns Indian consumer brands; FY26 revenue was ₹8,869 crore.
Filings cover: SomeUpdated for Q2 FY27 · checked
Sun Pharma
SUNPHARMASun Pharma makes medicines sold in more than 100 countries, including India and the US, earning ₹58,462 crore of revenue in FY26.
Filings cover: A lotUpdated for Q2 FY27 · checked
Torrent Pharma
TORNTPHARMTorrent Pharma makes branded medicines for India and Brazil and generic medicines for the US and Germany, earning ₹13,980 crore of revenue in FY26.
Filings cover: SomeUpdated for Q2 FY27 · checked
Zydus Lifesciences
ZYDUSLIFEZydus Lifesciences makes generic medicines for the US and branded medicines for India, and earned ₹27,148 crore of revenue in FY26.
Filings cover: A lotUpdated for Q2 FY27 · checked
The companies side by side
Each figure is from the company's own page, for its latest full financial year (April to March) unless a date is shown. Select a column heading to re-order the rows.
Net profit per ₹100 of revenue: Cityfort calculation from each company's annual numbers (net profit ÷ revenue × 100). Banks and NBFCs report total income (interest earned plus other income) as revenue, and free cash flow and debt-to-equity are not used for lenders. Free cash flow: cash from operations minus capital spending, as on each company's page. Debt-to-equity: borrowings ÷ net worth, as on each company's page for the balance-sheet date shown. Sources for every figure are on each company's page. ₹ crore, as each company reports.
How companies in this sector earn
How do Healthcare companies make money?
- Drug makers sell branded medicines through doctors' prescriptions in India, and cheaper generic copies abroad, mainly in the United States.
- Some firms make the active ingredients (APIs) that go into medicines, or make drugs under contract for other companies.
- Research, raw materials and the cost of meeting quality rules are the biggest costs for drug makers.
- Hospitals earn from each patient's bed stay, surgery and tests, so how full the beds are matters.
- Diagnostic labs earn a fee per test and depend on how many tests their collection centres bring in.
Who regulates it
Central Drugs Standard Control Organisation (CDSCO) · National Pharmaceutical Pricing Authority (NPPA) · Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers · US Food and Drug Administration (USFDA), for exports to the United States
What moves results across the sector
- US generic drug prices and USFDA inspection results at Indian plants.
- Price controls on essential medicines set by the NPPA.
- Prices of key ingredients imported from China, and the rupee-dollar exchange rate.
Words you'll meet
Key terms
- Generic drug
- A copy of a medicine whose patent has expired, sold at a lower price than the original.
- API (active pharmaceutical ingredient)
- The chemical in a medicine that produces its effect.
- USFDA observation
- A problem noted by the US drug regulator after inspecting a plant; serious findings can stop sales to the US.
- ANDA
- The application a company files to sell a generic drug in the United States.
- ARPOB
- Average revenue per occupied bed per day, a key figure for hospitals.
- Occupancy
- The share of a hospital's beds that are filled with patients.
Key facts
Healthcare in numbers
- How big is India's pharmaceutical industry?
- India's pharmaceutical turnover was ₹471,898 crore in FY25 (2024-25), per the Department of Pharmaceuticals. The department says the industry is the world's third largest by volume and eleventh largest by value. (Source: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India)
- How much medicine does India export and import?
- In FY25 (2024-25), India exported pharmaceuticals worth ₹245,962 crore and imported pharmaceuticals worth ₹63,573 crore, per the Department of Pharmaceuticals, citing DGCIS. (Source: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India)
Sources
- Annual Report 2025-26, Chapter 1: Overview, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, 2 Mar 2026
Last updated 25 Oct 2026.
Disclaimer
For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a SEBI-registered investment adviser.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Content is not an offer or solicitation to buy or sell any security.
Read the full disclaimerHide the full disclaimer
Cityfort publishes educational content that explains how listed companies work. Cityfort is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst and does not provide investment advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security.
All information is taken from publicly available sources, mainly company filings on BSE and NSE, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management are reported as statements, with their date and source; they are not our forecasts.